Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Israel’s 'Stonehenge’ not alone with near 30 similar sites, satellite imagery reveals - 25 Most Expected Film Delivery
- 3Step by step instructions to Safeguard Your Teeth During Sports Exercises
- 4Banks for High Fixed Store Rates: Augment Your Investment funds
- 5The most effective method to Shake Hands During a Pandemic: Wellbeing Tips and Behavior
- Why most Jewish Israelis back the death penalty for terrorists
- NASA Artemis II tracker: Where is the Orion now and when will it reach the moon?
- EU calls on Western Balkans to step up reforms for membership
- Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual
- 10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition
- Stunning new James Webb Space Telescope images reveal 'hidden' stars being born
- Paul Feig loves a plot twist. Why not reboot 'Die Hard' starring a woman?
- Rediscovering Euphoria: Individual Accounts of Conquering Despondency
- Doctors say changes to US vaccine recommendations are confusing parents and could harm kids
